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Verapamil, a calcium channel blocking agent, has been 
demonstrated to have depressive effects on the atrioven-
tricular (A V) node but not anomalous A V bypass tracts. 
Of 39 patients with A V reciprocating tachycardia uti-
lizing left-sided bypass tracts for retrograde conduction, 
intravenous infusion of verapamil (0.15 mg/kg) termi-
nated the tachycardia in 31 patients. Verapamil inter-
rupted the tachycardia circuit by inducing retrograde 
conduction block in the bypass tract rather than the A V 
node in 5 of these 31 patients. 
Electrophysiologic studies in these five patients re-
vealed that verapamil-induced conduction block in the 
bypass tract could be accounted for by two distinctly 
different mechanisms. In three patients, verapamil 
Verapamil, a calcium channel blocking agent, is effective 
for the treatment of reentrant supraventricular tachycardias. 
These include sinoatrial reentrant tachycardia, atrioventric-
ular (A V) nodal reentrant tachycardia and A V reciprocating 
tachycardia involving an anomalous A V bypass tract (1-5). 
The mechanism by which verapamil suppresses these reen-
trant supraventricular tachycardias is ascribed to its depres-
sive action on the sinoatrial and A V nodes. Several studies 
(3-5) have shown that verapamil has no depressive effects 
on the electrophysiologic properties of anomalous A V by-
pass tracts and that the site of verapamil-induced conduction 
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induced alternating slow and fast A V nodal conduction 
resulting in alternating long and short cycle lengths dur-
ing the tachycardia; consequently, development of the 
Ashman phenomenon in the bypass tract terminated the 
tachycardia. In the remaining two patients, the bypass 
tract exhibited properties similar to those of the A V 
node; verapamil prolonged the effective refractory pe-
riod of the bypass tract, thereby terminating the tachy-
cardia. Thus, depending on the functional properties of 
the bypass tract, verapamil may interrupt an A V recip-
rocating tachycardia circuit by exerting either a direct 
or indirect depressive action on the bypass tract. 
(J Am Coli Cardiol 1985;5:311-7) 
block during A V reciprocating tachycardia is located in the 
A V node. However, in the past 3 years, we have observed 
that verapamil may terminate A V reciprocating tachycardia 
by inducing conduction block in the anomalous A V bypass 
tract. This study describes the electrophysiologic mecha-
nisms responsible for this unique mode of tachycardia ter-
mination exerted by intravenous verapamil. 
Methods 
Patients. Between 1980 and 1983, we administered in-
travenous verapamil to 39 patients with inducible A V re-
ciprocating tachycardia during electrophysiologic studies. 
The tachycardia used the A V node-His-Purkinje system for 
anterograde conduction and a left-sided bypass tract for 
retrograde conduction. In keeping with findings of previous 
studies (3-5), verapamil consistently depressed A V nodal 
conduction as evidenced by prolongation of the A V nodal 
conduction time (AH interval) during tachycardia. In five 
patients. verapamil interrupted the reentrant circuit by in-
duction of retrograde conduction block in the bypass tract. 
Electrophysiologic data from these five patients were ana-
lyzed and their clinical profiles are summarized in Table I. 
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Table 1. Clinical Profile of Five Patients 
Age (yr) Clinical 
Case & Sex Tachycardia 
I 52M PSVT 
2 38F PSVT 
3 19M PSVT 
4 32M PSVT 
5 21F PSVT 
Rate of 
Tachycardia 
(beats/min) 
170 
ISO 
200 
ISO 
190 
Location of 
Bypass Tract 
L* 
L 
L 
L* 
L* 
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*Capable of retrograde conduction only. F = female; L = left-sided; M = male; PSVT = paroxysmal 
supraventricular tachycardia. 
Electrophysiologic study. All patients gave written in-
formed consent. Antiarrhythmic drugs were discontinued in 
all 48 to 72 hours before the study. The study was performed 
with patients in a postabsorptive nonsedated state. Using a 
conventional method (6), we introduced a tripolar electrode 
catheter from the right femoral vein and placed it in the 
right atrium against the septai leaflet of the tricuspid valve 
to record the His bundle potential. One quadripolar electrode 
catheter was introduced from the left antecubital or subcla-
vian vein and placed in the coronary sinus to record the left 
atrial electrogram. Additionally, two quadripolar electrode 
catheters were introduced from the right femoral vein and 
placed in the high right atrium and right ventricle, respec-
tively, for programmed electrical stimulation. Intracardiac 
electrograms were simultaneously displayed with electro-
cardiographic leads I, II and V I on a multichannel oscil-
loscopic recorder (Electronics for Medicine, VR -16) and 
were recorded at a paper speed of 100 minis using a filter 
frequency setting of 30 to 500 Hz. 
A programmed digital stimulator (Bloom and Associates) 
was used to deliver electrical impulses of 2.0 ms at approx-
imately twice diastolic .threshold. As previously described 
(7), programmed electrical stimulation, consisting of atrial 
and ventricular incremental pacing and extrastimulation, was 
performed first to ascertain anterograde and retrograde A V 
conduction patterns and the inducibility of supraventricular 
tachycardia. 
Administration of intravenous verapamil and repeat 
electro physiologic study. After control electrophysiologic 
data were obtained, verapamil at the dosage of 0.15 mg/kg 
of body weight was infused over 2 minutes during A V 
reciprocating tachycardia (4). Programmed electrical stim-
ulation was then repeated after termination of the tachy-
cardia to assess the overall effects of verapamil on anter-
ograde and retrograde A V conduction. In each patient, the 
time required to complete the repeat study was approxi-
mately 15 minutes. 
Electrophysiologic data. The definition and measure-
ment of A V conduction intervals in both anterograde and 
retrograde directions were conventional (7). The diagnostic 
criteria for A V reciprocating tachycardia involving an anom-
alous A V bypass tract were as described previously (7-9). 
Results 
Of the five patients, there were three men and two women 
ranging in age from 19 to 52 years. Clinically all had par-
oxysmal supraventricular tachycardia with rates varying from 
150 to 200 beats/min (Table I). In three (Cases I, 3 and 
4), anomalous A V bypass tracts were capable only of ret-
rograde conduction (concealed Wolff-Parkinson-White syn-
drome) (9). In all five patients, paroxysms of A V recipro-
cating tachycardia were readily inducible with either 
programmed atrial or ventricular stimulation, or both. In 
each instance, a left-sided bypass tract was used for retro-
grade conduction during the tachycardia. The sequence of 
retrograde atrial activation was first the left atrial activity 
recorded at the distal coronary sinus, followed by low septal 
right atrial and high right atrial activities (7-9). On the basis 
of the mode of tachycardia termination induced by intra-
venous verapamil, two distinctly different mechanisms could 
be identified. 
Indirect suppression of conduction of the anomalous 
A V bypass tract. In three patients (Cases I, 2 and 3), A V 
reciprocating tachycardia terminated after development of 
long and short cycle lengths within 3 minutes after intra-
venous infusion of verapamil. 
One example is illustrated in Figures I and 2. In Figure 
lA, the tachycardia has a cycle length of 360 ms, with 
corresponding A V nodal conduction time (AH interval) of 
160 ms during a control period. In Figure I B, a Val salva 
maneuver depresses A V nodal conduction and, as expected, 
interrupts the reentrant circuit by prolonging A V nodal re-
fractoriness (anterograde block in the AV node). The tachy-
cardia was then reinduced and intravenous verapamil ad-
ministered. First, this results in development of alternating 
long and short cycle lengths of 450 and 330 ms secondary 
to alternating slow and fast A V nodal conduction (AH in-
tervals of 250 and 130 ms, respectively) (Fig. 2A) (4,10). 
Then, the reentrant circuit is interrupted with development 
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Figure I. Case I. Effect of the Valsalva maneuver on 
atrioventricular (A V) reciprocating tachycardia. 
Electrocardiographic leads I. II and V 1 are simulta-
neously recorded with intracardiac electrograms of the 
high right atrium (HRA). His bundle (HBE) and distal 
coronary sinus (CSd). A. A V reciprocating tachycardia 
using a left-sided anomalous A V bypass tract for ret-
rograde conduction. The earliest retrograde atrial ac-
tivation is recorded at the distal coronary sinus (CSd). 
The cycle length of tachycardia is 360 ms and the 
corresponding A V nodal conduction time (AH interval) 
is 160 ms during the control period. B, The Valsalva 
maneuver prolongs A V nodal conduction time (AH 
interval) from 160 to 210 ms and terminates the tachy-
cardia by inducing anterograde block in the A V node. 
Figure 2. Case I. Termination of A V recip-
rocating tachycardia by an indirect depressive 
effect of verapamil on the anomalous A V bypass 
tract. Tracings A and B are continuous. A. After 
intravenous infusion of verapamil. there is de-
velopment of alternating long and short A V no-
dal conduction times (AH intervals) of 250 and 
130 ms, resulting in alternating long and short 
cycle lengths of 450 and 330 ms during the 
tachycardia. B, The tachycardia is terminated 
by subsequent development of retrograde con-
duction block in the anomalous A V bypass tract. 
Note that the development of conduction block 
in the bypass tract follows a short cycle length 
of 320 ms (AH interval of 120 ms), which is 
preceded by a long cycle length of 460 ms (AH 
interval of 260 ms), consistent with the Ashman 
phenomenon. Abbreviations as in Figure I. 
A 
B 
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of retrograde conduction block in the anomalous A V bypass 
tract (Fig. 28). Noteworthy is that the development of con-
duction block in the bypass tract follows a short cycle length 
(320 ms) which is preceded by a long cycle length (460 ms) 
consistent with the Ashman phenomenon (II). In none of 
these three patients were effective refractory periods of the 
atrium and the bypass tract prolonged by intravenous ver-
apamil (3,4). This latter finding inferred that the develop-
ment of conduction block in the bypass tract was indeed 
related to alteration of the tachycardia cycle length. 
Direct suppression of conduction of the anomalous 
AV bypass tract. In the remaining two patients (Cases 4 
and 5), intravenous verapamil seemed to have direct de-
pressive effects on conduction of the anomalous A V bypass 
tract. In both patients, the bypass tract was located left 
Figure 3. Case 4. Termination of A V reciprocating tachycardia 
by a direct depressive effect of verapamil on the anomalous A V 
bypass tract. A, A V reciprocating tachycardia is initiated by an 
atrial premature beat (52) with a premature coupling interval (5 152) 
of 210 ms during a basic driving cycle length (5 15 1) of 600 ms. 
During the tachycardia, the earliest retrograde atrial activation is 
recorded at the distal coronary sinus (C5d). Note that the ventric-
uloatrial (V A) conduction time measured from the distal coronary 
sinus progressively prolongs from 90 to 130 ms as A V nodal 
conduction time (AH interval) gradually shortens from 160 to 80 
ms. B, Verapamil prolongs AV nodal conduction time (AH interval 
180 to 200 ms) and VA conduction time (140 ms) and terminates 
A V reciprocating tachycardia by inducing retrograde conduction 
block in the bypass tract. Other abbreviations as in Figure I. 
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laterally, but exhibited electrophysiologic properties similar 
to those of the A V node. Intravenous verapamil prolonged 
conduction time and refractoriness of both the A V node and 
the bypass tract and terminated A V reciprocating tachycar-
dia by inducing retrograde conduction block in the bypass 
tract. 
Examples are presented in Figures 3 to 5. In Figure 3A, 
A V reciprocating tachycardia is initiated by an atrial pre-
mature beat (S2) with a premature coupling interval (S I S2) 
of 210 ms during an atrial driving cycle length (SISd of 
600 ms. The tachycardia uses the A V node-His-Purkinje 
system for anterograde conduction and a left-sided bypass 
tract for retrograde conduction. Before verapamil infusion, 
ventriculoatrial (V A) conduction time through the bypass 
tract (measured from the distal coronary sinus) gradually 
lengthens from 90 to 130 ms as A V nodal conduction time 
(AH interval) shortens from 160 to 80 ms. In Figure 3B, 
intravenous infusion of verapamil prolongs A V nodal con-
duction time (AH interval) to 180 to 200 ms and VA con-
duction time through the bypass tract to 140 ms, and in-
terrupts the reentrant circuit by inducing retrograde conduction 
block in the bypass tract. 
Incremental ventricular pacing and programmed ven-
tricular extrastimulation before and after verapamil infusion 
characterized the electrophysiologic properties of the anom-
alous A V bypass tract. In Figure 4A, right ventricular pacing 
at a cycle length of 350 ms, there is I: 1 VA conduction by 
way of the bypass tract. V A conduction time measured from 
the distal coronary sinus is 160 ms. In Figure 4B, shortening 
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Figure 4. Case 4. Effects of intravenous 
verapamil on ventriculoatrial (V A) conduc-
tion during incremental ventricular pacing. 
A, During right ventricular pacing at a cycle 
length (SS) of 350 ms there is I : I V A con-
duction. The sequence of retrograde atrial 
activation is identical to that observed during 
A V reciprocating tachycardia (Fig. 3) and is 
recorded earliest at the distal coronary sinus 
(CSd), followed by the His bundle (HBE) 
and high right atrial (HRA) electrographic 
leads. VA conduction time measured from 
the distal coronary sinus is 160 ms. B, Right 
ventricular pacing at a cycle length (SS) of 
300 ms induces second degree (Wenckebach) 
VA block in the bypass tract. C, After in-
travenous infusion of verapamil, complete 
V A block develops during right ventricular 
pacing at a cycle length (SS) of 450 ms. 
A 
B 
c P VERAPAMIL 
of the ventricular pacing cycle length to 300 ms induced 
prolongation of V A conduction time, leading to the devel-
opment of a second degree VA block of the Wenckebach 
type in the bypass tract. In Figure 4C, intravenous infusion 
of verapamil produces complete V A block at a ventricular 
pacing cycle length of 450 ms. 
VA conduction curves (V,V2 , V2A2 ) generated with pro-
grammed ventricular extrastimulation are shown in Figure 
5. Before intravenous infusion of vera pam ii, VA conduction 
time (VzA z) by way of the bypass tract (measured from the 
distal coronary sinus) gradually lengthens from 130 to 190 
ms as the ventricular premature coupling interval progres-
sively shortens. The retrograde effective refractory period 
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500ms 
of the bypass tract is 280 ms. After intravenous infusion of 
verapamil, V A conduction time (V 2A2) is lengthened to 200 
ms and the retrograde effective refractory period of the 
bypass tract is markedly prolonged to 460 ms. These find-
ings (Fig. 3 to 5) clearly demonstrated that the bypass tract 
exhibited electrophysiologic properties similar to those of 
the A V node and suggested direct depressive effects of 
verapamil on the bypass tract. 
Discussion 
In atrioventricular (A V) reciprocating tachycardia, intra-
venous verapamil depresses A V nodal conduction and may 
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Figure 5. Case 4. Effects of intravenous verapamil on ventricu-
loatrial (V A) conduction curves generated by programmed right 
ventricular extrastimulation at a cycle length of 600 ms. The V A 
conduction time (V 2A2) measured from the distal coronary sinus 
is plotted against the premature coupling intervals (V 1-V 2) of ven-
tricular premature beats. The circles represent atrial responses 
during the control period and the triangles represent atrial re-
sponses after the intravenous infusion of verapamil. During the 
control period, V A conduction time (V 2A2) gradually lengthens 
from 130 to 190 ms and the ventricular premature coupling inter-
vals (V 1-V2) progressively shorten. The effective refractory period 
of V A conduction (bypass tract) is 280 ms. After the intravenous 
infusion of verapamil, the VA conduction curve shifts upward and 
to the right. V A conduction time (V 2A2) lengthens to 200 ms and 
the effective refractory period of V A conduction (bypass tract) is 
increased to 460 ms. 
thereby interrupt the reentrant circuit and convert the ar-
rhythmia to sinus rhythm (I-S). In the present study, we 
demonstrated that intravenous verapamil may terminate A V 
reciprocating tachycardia by exerting a direct or indirect 
depressive action on the anomalous A V bypass tract. 
Indirect suppression of conduction of the anomalous 
A V bypass tract. Intravenous verapamil usually has no 
significant effects on electrophysiologic properties of the 
anomalous A V bypass tract. This is because, unlike the A V 
nodal structure, a bypass tract generally consists of a work-
ing myocardium bridging the atrium and the ventricle (12-14). 
During A V reciprocating tachycardia, intravenous verapa-
mil prolongs conduction time and refractoriness of the A V 
node, but not of the bypass tract (2-S). Consequently, the 
cycle length of A V reciprocating tachycardia is lengthened. 
In some instances, intravenous verapamil produces alter-
nating long and short cycle lengths with alternating slow 
and fast A V nodal conduction (AH interval) (4,10). With 
the exception of the A V node, a long cycle length increases 
the refractory period of normal cardiac tissue, while a short 
cycle length has the opposite effect (IS-17). Functional 
block in the bundle branches (the Ashman phenomenon) 
thus tends to develop in the beat with a short cycle length, 
which is preceded by a long cycle length (11,18). The ob-
servations made in our three patients (Cases I, 2 and 3) 
JACC Vol. 5. No.2 
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suggest that the Ashman phenomenon can also occur in the 
bypass tract, particularly during A V reciprocating tachy-
cardia with verapamil-induced alternating long and short 
cycle lengths. 
Direct suppression of conduction of the anomalous 
A V bypass tract. There are two possible considerations of 
the anatomic substrate of a bypass tract that exhibits prop-
erties similar to those of the A V node: I) nonhomogeneous 
physiologic properties of individual myocardial fibers or 
longitudinal dissociation of the myocardial fibers that make 
up the bypass tract, and 2) the bypass tract containing cells 
with histologic characteristics of A V nodal cells (14). In 
most instances, the bypass tract with A V node-like prop-
erties has been described as being located in or close to the 
atrial septum nearby the AV junction (19-23). An "acces-
sory" A V node was suggested by some investigators be-
cause of its proximity to the A V node. The two patients 
(Cases 4 and S) we encountered are unique in that I) both 
had a left-sided lateral bypass tract that was located far away 
from the A V node but had A V node-like properties, and 2) 
conduction of this bypass tract was suppressible with intra-
venous verapamil. These findings suggest that these bypass 
tracts probably contain cells with cali urn-dependent slow 
channel responses similar to those of the A V node. 
Clinical and electrophysiologic implications. De-
pending on functional properties of the anomalous A V by-
pass tract, intravenous verapamil may depress conduction 
of the bypass tract during A V reciprocating tachycardia. 
Directly, verapamil can prolong conduction and refracto-
riness of a bypass tract that possesses A V node-like prop-
erties. Indirectly, verapamil may induce alternating long and 
short cycle lengths that may, in turn, lead to development 
of the Ashman phenomenon in the bypass tract. 
Patients with an anomalous A V bypass tract with such 
properties may be more common than would be expected, 
and intravenous verapamil is quite useful for terminating 
the A V reciprocating tachycardia in these patients. How-
ever, intravenous verapamil should not be given to patients 
who manifest predominantly ventricular pre-excitation dur-
ing atrial flutter-fibrillation (4,S,24). This is because vera-
pamil may decrease the bypass tract refractory period through 
a reflex increase in the sympathetic tone brought about by 
its hypotensive effect (24). 
We thank Jan Perini for excellent secretarial assistance in preparing this 
manuscript. 
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